Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC Stabilization.
Journal
Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
14
11
2019
revised:
15
02
2020
accepted:
12
03
2020
pubmed:
20
3
2020
medline:
1
10
2021
entrez:
20
3
2020
Statut:
ppublish
Résumé
Although mutations in the gene encoding the RNA splicing factor SF3B1 are frequent in multiple cancers, their functional effects and therapeutic dependencies are poorly understood. Here, we characterize 98 tumors and 12 isogenic cell lines harboring
Identifiants
pubmed: 32188705
pii: 2159-8290.CD-19-1330
doi: 10.1158/2159-8290.CD-19-1330
pmc: PMC8188517
mid: NIHMS1578078
doi:
Substances chimiques
Phosphoproteins
0
RNA Splicing Factors
0
SF3B1 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
806-821Subventions
Organisme : NCI NIH HHS
ID : R01 CA185486
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA179044
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL128239
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA193313
Pays : United States
Organisme : NCI NIH HHS
ID : P01 CA087497
Pays : United States
Organisme : NCI NIH HHS
ID : K99 CA218896
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
©2020 American Association for Cancer Research.
Références
Cancer Cell. 2016 Sep 12;30(3):404-417
pubmed: 27622333
N Engl J Med. 2011 Dec 29;365(26):2497-506
pubmed: 22150006
Sci Transl Med. 2018 Jul 18;10(450):
pubmed: 30021885
N Engl J Med. 2011 Oct 13;365(15):1384-95
pubmed: 21995386
Lancet Oncol. 2013 May;14(6):e229-38
pubmed: 23639323
J Biol Chem. 2002 Jun 14;277(24):21453-7
pubmed: 11967257
Blood. 2018 Sep 20;132(12):1225-1240
pubmed: 29930011
Mol Cell Biol. 2006 Apr;26(7):2832-44
pubmed: 16537924
Cancer Cell. 2018 Aug 13;34(2):225-241.e8
pubmed: 30107174
N Engl J Med. 2012 Jun 28;366(26):2530
pubmed: 22738114
J Biol Chem. 2002 Jun 21;277(25):22847-52
pubmed: 11929874
Mol Cell Biol. 1993 Apr;13(4):2432-40
pubmed: 8455620
Int J Hematol. 2017 Jun;105(6):720-731
pubmed: 28466384
Pharmacol Ther. 2005 Dec;108(3):308-19
pubmed: 15951022
PLoS One. 2017 Nov 30;12(11):e0188910
pubmed: 29190822
Cancer Discov. 2013 Oct;3(10):1122-1129
pubmed: 23861464
Nature. 2019 Oct;574(7778):432-436
pubmed: 31597964
Nature. 1985 Dec 12-18;318(6046):533-8
pubmed: 3906410
Cancer Res. 2015 May 15;75(10):1949-58
pubmed: 25788694
Nat Genet. 2017 Jun;49(6):866-875
pubmed: 28436985
Cell Rep. 2015 Nov 3;13(5):1033-45
pubmed: 26565915
Cell Rep. 2018 Apr 3;23(1):282-296.e4
pubmed: 29617667
Nat Genet. 2013 Feb;45(2):133-5
pubmed: 23313955
Br J Pharmacol. 2003 Apr;138(7):1303-12
pubmed: 12711631
J Biol Chem. 2007 Jan 5;282(1):5-13
pubmed: 17082179
Nat Med. 2018 May;24(4):497-504
pubmed: 29457796
Nat Struct Mol Biol. 2007 Jun;14(6):527-34
pubmed: 17529992
Nat Rev Cancer. 2016 Jul;16(7):413-30
pubmed: 27282250
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):153-8
pubmed: 14660795
Nat Cell Biol. 2004 Apr;6(4):308-18
pubmed: 15048125
Nature. 2011 Sep 11;478(7367):64-9
pubmed: 21909114
Cancer Res. 2010 Dec 15;70(24):10474-84
pubmed: 21159657
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830869
J Biol Chem. 1998 Nov 6;273(45):29794-800
pubmed: 9792694
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Mol Cell. 2016 Oct 20;64(2):307-319
pubmed: 27720643
J Clin Invest. 2014 Feb;124(2):644-55
pubmed: 24401270
PLoS Comput Biol. 2015 Mar 13;11(3):e1004105
pubmed: 25768983
Nature. 2019 Oct;574(7777):273-277
pubmed: 31578525
Cancer Cell. 2016 Nov 14;30(5):750-763
pubmed: 27818134
Mol Syst Biol. 2010 Jun 8;6:377
pubmed: 20531406
Nat Genet. 2013 Aug;45(8):933-6
pubmed: 23793026
EMBO Mol Med. 2013 Jan;5(1):105-21
pubmed: 23180565